News HLB Co., Ltd.

Equities

A028300

KR7028300002

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
101,000 ^KRW	-4.36%		-5.16%	+99.21%

Apr. 01	HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	CI
Mar. 22	HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	Mar. 31	CI
HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	Mar. 22	MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 29.99999658 billion in funding from HLB Co., Ltd. and other investors	Mar. 21	CI
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
HLB Co., Ltd. announced that it has received KRW 60 billion in funding from a group of investors	Mar. 07	CI
HLB Co., Ltd. announced that it expects to receive KRW 60 billion in funding from a group of investors	Mar. 03	CI
Bank of Canada Holds Rates Steady; ECB Expected -2-	Jan. 25	DJ
South Korean Shares Marginally Decline for Second Day on Profit-Booking	Dec. 22	MT
HLB Shareholders Endorse Transition to Main Bourse from KOSDAQ	Dec. 22	MT
BPH Energy Appoints HLB Mann Judd as Auditor; Shares Plunge 10%	Nov. 21	MT
Century Sunshine Group’s Auditor Resigns; Successor Named	Nov. 17	MT
Rare Earth Magnesium’s Auditor Steps Down; Successor Appointed	Nov. 17	MT
Jinhai International Gets New Auditor	Nov. 14	MT
HLB Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
HLB, Hong Leong Islamic Bank, Cagamas Conclude MYR300 Million Green Assests Deal	23-10-04	MT
Spenda Halts Trade Pending Court Nod for Auditor Appointment	23-09-04	MT
5E Resources Appoints New Auditors	23-09-01	MT
Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.	23-08-10	CI
Elevar Therapeutics, Inc. announced that it expects to receive KRW 58.174676146 billion in funding from HLB Co., Ltd.	23-08-08	CI
Hong Leong Bank Digital Banking Platforms Grow 22% as of May	23-07-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News HLB Co., Ltd.

Equities

A028300

KR7028300002

Summary

Filters